Thousands of Patiences in English Will Be Able to Access Weight-Loss Jabs Via Their GP from Monday for the first time.
The Mass Rollout on the NHS Means Family Doctors Will Belowed to Prescybery the Drugs for the First Time. About 220,000 People with “Great Need” are expected to receive mounjaro, also Known as Tirzepatide and Made by Eli Lilly, on the NHS Over the Next Three Years.
The Dru Works by Lowering Blood Sugar Levels and Slos Download How Quickly Food is Digested.
From Monday, Gps in England Will Belowed to Prescripe Mounjaro to Severely Obse People Living With a Range of Other Health Problems. Patients Prevringly Needed to Access The Drug Srough A Special Weight Loss Service.
GP leaders said some Family Doctors Had Expressed Concern About the Additional Workload, While Pharmacy Experts Also SAID ThERE COULD Be Pressure on Supplies of the Drug.
In the first year of the program, it will be offield to People with a Body Mass Index (BMI) Score of More Than 40 Who has at least For other Health Problems Link to Obesity Such as Type 2 Diabets, High Blood Pressure, Heart Disease and Obstructive Sleep Apnoea.
Estimates Sugges about 1.5 Million People in the UK Are Already Taking Weight-Loss Drugs, Whiche May Have Been Presccric Thrug Specialist Weight Loss Services or Via Private Presscription.
PROF KAMILA Hawthorne, The Chair of the Royal College of GPS, Said: “While We Recography the Potential Benefits of Weight-Loss Drugs, We Known Many Gps Are Conceptor about the Implications of the Rollout of Weight-Loss Drugs Into General Practice, Both in TERMS of Workload and Trainal to Approprialy initiate and Manage these treatments.
“GPS and our texts are already working undid call workload and workforce previouss, and this must be faqured into this roll in order to Guarante IT can be deliedred savely.
“More Widily, While Weight-Loss Medications Have a Lot of Potential Benefits for Pations Who Are Strunging to Lose Weight and Who Meet All The Clinical Criteria for A Prescyption, They MUSTNTT Be Seen AS A ‘Silver Bullet’ To Aid Weight Loss.
“We also need to see a foCUS on Prevention, Stopping People BecChoing Overweight in the First Place So they don’t request a media intervention later.”
Olivier Picard, The Chair of the National Pharmacy Association, SAID The Demand for Weight-Loss Jabs Continied to Rise Sharply.
“As the NHS is now moving to imgement national Institute for Health and Care Excel between Volumes Increase Rapidly, ”He said.
“Howver, NHS Provision Won’t Meet Demand Straight Away, So We Fully Expecting that Many People Will Continue Seeing it Privately from a Pharmacy.”
